Media headlines about Dolby Laboratories (NYSE:DLB) have trended somewhat positive on Sunday, Accern reports. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dolby Laboratories earned a news impact score of 0.13 on Accern’s scale. Accern also assigned news articles about the electronics maker an impact score of 45.2193706569027 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Several research analysts recently weighed in on the stock. B. Riley set a $66.00 price objective on shares of Dolby Laboratories and gave the stock a “buy” rating in a research report on Thursday, October 19th. Dougherty & Co restated a “buy” rating and issued a $63.00 price objective on shares of Dolby Laboratories in a research report on Wednesday, September 13th. Zacks Investment Research cut shares of Dolby Laboratories from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 31st. Piper Jaffray Companies restated a “hold” rating and issued a $52.00 price objective (up from $49.00) on shares of Dolby Laboratories in a research report on Wednesday, September 13th. Finally, BidaskClub cut shares of Dolby Laboratories from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 22nd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $60.17.
Shares of Dolby Laboratories (DLB) traded up $0.74 during midday trading on Friday, reaching $61.79. 226,734 shares of the company’s stock were exchanged, compared to its average volume of 310,955. Dolby Laboratories has a twelve month low of $44.99 and a twelve month high of $63.34. The company has a market capitalization of $6,320.38, a PE ratio of 29.71, a P/E/G ratio of 2.29 and a beta of 0.86.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, November 6th were given a dividend of $0.16 per share. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date of this dividend was Friday, November 3rd. Dolby Laboratories’s dividend payout ratio (DPR) is presently 32.99%.
In other Dolby Laboratories news, CMO Bob Borchers sold 50,000 shares of the stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $62.72, for a total transaction of $3,136,000.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Kevin J. Yeaman sold 45,000 shares of the stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $56.46, for a total transaction of $2,540,700.00. The disclosure for this sale can be found here. Insiders have sold 570,095 shares of company stock worth $34,617,013 over the last quarter. Company insiders own 43.80% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.